These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22629460)

  • 1. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake.
    Santoro N; Savoye M; Kim G; Marotto K; Shaw MM; Pierpont B; Caprio S
    PLoS One; 2012; 7(5):e37827. PubMed ID: 22629460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Low ω-6 to ω-3 PUFA Ratio (n-6:n-3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth.
    Van Name MA; Savoye M; Chick JM; Galuppo BT; Feldstein AE; Pierpont B; Johnson C; Shabanova V; Ekong U; Valentino PL; Kim G; Caprio S; Santoro N
    J Nutr; 2020 Sep; 150(9):2314-2321. PubMed ID: 32652034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.
    Santoro N; Kursawe R; D'Adamo E; Dykas DJ; Zhang CK; Bale AE; Calí AM; Narayan D; Shaw MM; Pierpont B; Savoye M; Lartaud D; Eldrich S; Cushman SW; Zhao H; Shulman GI; Caprio S
    Hepatology; 2010 Oct; 52(4):1281-90. PubMed ID: 20803499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption.
    Davis JN; Lê KA; Walker RW; Vikman S; Spruijt-Metz D; Weigensberg MJ; Allayee H; Goran MI
    Am J Clin Nutr; 2010 Dec; 92(6):1522-7. PubMed ID: 20962157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants.
    Santoro N; Feldstein AE; Enoksson E; Pierpont B; Kursawe R; Kim G; Caprio S
    Diabetes Care; 2013 May; 36(5):1353-60. PubMed ID: 23275357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.
    Santoro N; Zhang CK; Zhao H; Pakstis AJ; Kim G; Kursawe R; Dykas DJ; Bale AE; Giannini C; Pierpont B; Shaw MM; Groop L; Caprio S
    Hepatology; 2012 Mar; 55(3):781-9. PubMed ID: 22105854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
    Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
    Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
    Finkenstedt A; Auer C; Glodny B; Posch U; Steitzer H; Lanzer G; Pratschke J; Biebl M; Steurer M; Graziadei I; Vogel W; Zoller H
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1667-72. PubMed ID: 23872669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L; Rumi M; Galmozzi E; Aghemo A; Del Menico B; De Nicola S; Dongiovanni P; Maggioni M; Fracanzani AL; Rametta R; Colombo M; Fargion S
    Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
    Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-Week Omega-3 Supplementation in Carriers of the Prosteatotic PNPLA3 p.I148M Genetic Variant: An Open-Label Study.
    Kuttner CS; Mancina R; Wagenpfeil G; Lammert F; Stokes CS
    Lifestyle Genom; 2019; 12(1-6):10-17. PubMed ID: 31454802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth.
    Monga Kravetz A; Testerman T; Galuppo B; Graf J; Pierpont B; Siebel S; Feinn R; Santoro N
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3575-85. PubMed ID: 32561908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents.
    Goran MI; Walker R; Le KA; Mahurkar S; Vikman S; Davis JN; Spruijt-Metz D; Weigensberg MJ; Allayee H
    Diabetes; 2010 Dec; 59(12):3127-30. PubMed ID: 20852027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
    BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
    Xia MF; Lin HD; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Bian H; Li XY; Gao X
    Diabetologia; 2019 Apr; 62(4):644-654. PubMed ID: 30673802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
    Kantartzis K; Peter A; Machicao F; Machann J; Wagner S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
    Diabetes; 2009 Nov; 58(11):2616-23. PubMed ID: 19651814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
    Lin YC; Chang PF; Hu FC; Yang WS; Chang MH; Ni YH
    J Pediatr; 2011 May; 158(5):740-4. PubMed ID: 21168155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.
    Mandorfer M; Scheiner B; Stättermayer AF; Schwabl P; Paternostro R; Bauer D; Schaefer B; Zoller H; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferenci P; Ferlitsch A
    Aliment Pharmacol Ther; 2018 Aug; 48(4):451-459. PubMed ID: 29956823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.
    Giudice EM; Grandone A; Cirillo G; Santoro N; Amato A; Brienza C; Savarese P; Marzuillo P; Perrone L
    PLoS One; 2011; 6(11):e27933. PubMed ID: 22140488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.